Holly C Gooding1, Sarah D de Ferranti. 1. Division of Adolescent/Young Adult Medicine, Department of Medicine, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA. holly.gooding@childrens.harvard.edu
Abstract
PURPOSE OF REVIEW: Adolescence is a common time for the identification of cardiovascular disease risk factors, including elevated cholesterol. Guidelines for the detection and treatment of hypercholesterolemia differ for children and adults. This review highlights these differences and discusses special considerations for cholesterol management in the adolescent population. RECENT FINDINGS: Several longitudinal studies have confirmed that the number of cardiovascular risk factors present in adolescence, including elevated cholesterol, lead to atherosclerosis in adults. There is increased awareness that other chronic medical conditions, including diabetes, congenital heart disease, inflammatory diseases, and childhood cancer, can accelerate this process. There is a move to screen and treat more young patients with elevated cholesterol to prevent future cardiovascular disease. New markers of atherosclerosis are being used to quantify cardiovascular disease risk in adolescents in research populations. The safety and efficacy of several interventions, including drug therapy, is increasingly established. SUMMARY: Comprehensive cardiovascular risk assessment is important for adolescent health and includes assessment of family history and tobacco use along with measurement of body mass index and blood pressure. Additionally, cholesterol screening is recommended for overweight adolescents or those with an unknown family history and for all patients by the age of 20. Providers caring for adolescents should be familiar with both the pediatric and adult cholesterol screening and treatment guidelines as well as how common adolescent conditions affect cholesterol levels.
PURPOSE OF REVIEW: Adolescence is a common time for the identification of cardiovascular disease risk factors, including elevated cholesterol. Guidelines for the detection and treatment of hypercholesterolemia differ for children and adults. This review highlights these differences and discusses special considerations for cholesterol management in the adolescent population. RECENT FINDINGS: Several longitudinal studies have confirmed that the number of cardiovascular risk factors present in adolescence, including elevated cholesterol, lead to atherosclerosis in adults. There is increased awareness that other chronic medical conditions, including diabetes, congenital heart disease, inflammatory diseases, and childhood cancer, can accelerate this process. There is a move to screen and treat more young patients with elevated cholesterol to prevent future cardiovascular disease. New markers of atherosclerosis are being used to quantify cardiovascular disease risk in adolescents in research populations. The safety and efficacy of several interventions, including drug therapy, is increasingly established. SUMMARY: Comprehensive cardiovascular risk assessment is important for adolescent health and includes assessment of family history and tobacco use along with measurement of body mass index and blood pressure. Additionally, cholesterol screening is recommended for overweight adolescents or those with an unknown family history and for all patients by the age of 20. Providers caring for adolescents should be familiar with both the pediatric and adult cholesterol screening and treatment guidelines as well as how common adolescent conditions affect cholesterol levels.
Authors: E Obarzanek; S Y Kimm; B A Barton; L Van Horn L; P O Kwiterovich; D G Simons-Morton; S A Hunsberger; N L Lasser; A M Robson; F A Franklin; R M Lauer; V J Stevens; L A Friedman; J F Dorgan; M R Greenlick Journal: Pediatrics Date: 2001-02 Impact factor: 7.124
Authors: H C McGill; C A McMahan; A W Zieske; R E Tracy; G T Malcom; E E Herderick; J P Strong Journal: Circulation Date: 2000-07-25 Impact factor: 29.690
Authors: Jose Castro-Perez; Stephen F Previs; David G McLaren; Vinit Shah; Kithsiri Herath; Gowri Bhat; Douglas G Johns; Sheng-Ping Wang; Lyndon Mitnaul; Kristian Jensen; Robert Vreeken; Thomas Hankemeier; Thomas P Roddy; Brian K Hubbard Journal: J Lipid Res Date: 2010-09-30 Impact factor: 5.922
Authors: Samantha K Sliwinski; Holly Gooding; Sarah de Ferranti; Thomas I Mackie; Supriya Shah; Tully Saunders; Laurel K Leslie Journal: J Clin Lipidol Date: 2016-11-09 Impact factor: 4.766
Authors: Laney K Jones; Samuel S Gidding; Terry L Seaton; Anne Goldberg; Christina Gregor; Amy C Sturm; Ross C Brownson; Alanna Kulchak Rahm; Marc S Williams Journal: Res Social Adm Pharm Date: 2019-06-15
Authors: Audrey A Opoku-Acheampong; Richard R Rosenkranz; Koushik Adhikari; Nancy Muturi; Cindy Logan; Tandalayo Kidd Journal: Int J Environ Res Public Health Date: 2021-12-17 Impact factor: 3.390